A Pilot Study of F-18 Paclitaxel (FPAC) PET for Evaluating Drug Delivery of Solid Tumors in Breast, Lung, Renal, and Adrenal Cancers

Clinical trial NCT01086696 · TERMINATED

Trial details

NCT number: NCT01086696
Sponsor: National Cancer Institute (NCI)
Status: TERMINATED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Breast Cancer Lung Cancer Renal Cancer Adrenal Cancer

Start date: 2010-03-09
Primary completion: 2014-08-20
Enrollment: 6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.